N.B. pharmacists' association unhappy with new policyThe executive director of the New Brunswick Pharmacists’ Association has spoken out about the impact the province’s new generic policy will have on the profession. Sluggish approvals slow access to new drugs: Fraser InstituteCanadians are waiting nearly 2-1/2 years for government bureaucracies to approve new prescription drugs for public use, says a report from public policy think-tank the Fraser Institute. The Medical Post table of contents: April 10, 2012 print edition All the news from the April 10 issue How Saskatoon's pharmacists are handling drug shortages Having established relationships and communication channels are key. How to initiate insulin therapy in type 2 diabetes New systematic review and meta-analysis examines insulin therapy. New risk statements required for benzocaine product labels New statements focus on the risk of methemoglobinemia and how to recognize its signs and symptoms. Atlantic pharmacies pilot therapeutic substitution Prompted by legislation around pharmacists’ expanded scope of practice, Medavie Blue Cross is conducting a pilot that could help determine fee-for-service models in the future. Drug reforms will hit NB pharmacies hard: Blanchard Despite government incentives, the New Brunswick Pharmacists Association is grappling with disparities in drug reforms compared to other provinces. Drug shortages: what is the industry doing? Manufacturers support healthcare professionals in the short-term, but say uncovering long-term solution is the real priority. Alberta Premier stresses PC party’s commitments to pharmacy during election campaign Redford stops in front of pharmacy to stress the Tories’ commitment to improving patients’ access to pharmacists. Duelling guidelines? Canadian and U.S. guidelines for acute sinusitis differ in diagnosis, treatment INNOVATORS: A hero to elderly patients Dr. John Sloan’s approach to care for senior patients helps keep them at home and out of the hospital First Previous 825 826 827 828 829 Next Last
